ProfessorDanijela Gnjidic
Head of Pharmacoepidemiology & Medication Safety (L2 Supervisor)
Faculty of Medicine and Health
- Head of Pharmacoepidemiology & Medication Safety (L2 Supervisor)Faculty of Medicine and Health
BIO
BSc (Hons) PhD MPH
Danijela Gnjidic is a Professor and Head of Pharmacoepidemiology and Medication Safety, School of Pharmacy, Faculty of Medicine and Health, University of Sydney. Her research expertise is in clinical and geriatric pharmacology, deprescribing, pharmacoepidemiology, and the quality use of medicines. Danijela completed her doctoral training at the University of Sydney in 2010. She also undertook and completed a Masters of Public Health, concurrently with her PhD. Following her doctoral training, Danijela conducted post-doctoral training at the University of Eastern Finland where she furthered her geriatric pharmacology and pharmacoepidemiology research.
Danijela's academic track records includes 215 publications, 3-book chapters and $20M in research funding including University of Sydney Thompson Fellowship (2023), NHMRC Dementia Leadership Fellowship (2017-21), University of Sydney Bridging Support Fellowship (2016), and NHMRC Early Career Fellowship (2012-15). Danijela was awarded the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Denis Wade Johnson & Johnson New Investigator Award in 2012, and the American Society of Clinical Pharmacology and Therapeutics (ASCPT) William B. Abrams award in Geriatric Clinical Pharmacology in 2019. In 2026, Danijela was elected as a Fellow of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Society.
Danijela is a previous Interim Deputy Associate Dean of Research, Faculty of Medicine and Health (2025), Research Academic Director, Faculty of Medicine and Health (2023-24, 2026), Executive Editor of the British Journal of Clinical Pharmacology (2020-24), Executive Member (2018-22), Australian Deprescribing Network (ADeN), Past President (2020-21), ASCEPT and Chair (2022-23), Geriatric Pharmacoepidemiology Special Interest Group, International Society for Pharmacoepidemiology (ISPE). Danijela was a Deputy Chair (2022-26) of the HDR Examinations Sub-Committee, University of Sydney.
SCHOOL
- Sydney Pharmacy School